Literature DB >> 10984510

Fully competent dendritic cells as inducers of T cell anergy in autoimmunity.

S Quaratino1, L P Duddy, M Londei.   

Abstract

Mature immunologically competent dendritic cells are the most efficient antigen-presenting cells that powerfully activate T cells and initiate and sustain immune responses. Indeed, dendritic cells are able to efficiently capture antigens, express high levels of costimulatory molecules, and produce the combination of cytokines required to create a powerful immune response. They are also considered to be important in initiating autoimmune disease by efficiently presenting autoantigens to self-reactive T cells that, in this case, will mount a pathogenic autoimmune reaction. Triggering T cells is not a simple on-off procedure, as T cell receptor responds to minor changes in ligand with gradations of T cell activation and effector functions. These "misfit" peptides have been called Altered Peptide Ligands, and have been shown to have important biological significance. Here, we show that fully capable dendritic cells may present, upon natural antigen processing, a self-epitope with Altered Peptide Ligands features that can unexpectedly induce anergy in a human autoreactive T cell clone. These results indicate that presentation of a self-epitope by immunologically competent dendritic cells does not always mean "danger" and show a mechanism involved in the fine balance between activation and tolerance induction in humans.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10984510      PMCID: PMC27123          DOI: 10.1073/pnas.190204697

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

Review 1.  Dendritic cells and the control of immunity.

Authors:  J Banchereau; R M Steinman
Journal:  Nature       Date:  1998-03-19       Impact factor: 49.962

Review 2.  Origin, maturation and antigen presenting function of dendritic cells.

Authors:  M Cella; F Sallusto; A Lanzavecchia
Journal:  Curr Opin Immunol       Date:  1997-02       Impact factor: 7.486

3.  Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells.

Authors:  M Cella; A Engering; V Pinet; J Pieters; A Lanzavecchia
Journal:  Nature       Date:  1997-08-21       Impact factor: 49.962

4.  Similar antigenic surfaces, rather than sequence homology, dictate T-cell epitope molecular mimicry.

Authors:  S Quaratino; C J Thorpe; P J Travers; M Londei
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

5.  Neonatal tolerance revisited: turning on newborn T cells with dendritic cells.

Authors:  J P Ridge; E J Fuchs; P Matzinger
Journal:  Science       Date:  1996-03-22       Impact factor: 47.728

6.  Split activity of interleukin-10 on antigen capture and antigen presentation by human dendritic cells: definition of a maturative step.

Authors:  A S Morel; S Quaratino; D C Douek; M Londei
Journal:  Eur J Immunol       Date:  1997-01       Impact factor: 5.532

Review 7.  Models of T cell anergy: is there a common molecular mechanism?

Authors:  R H Schwartz
Journal:  J Exp Med       Date:  1996-07-01       Impact factor: 14.307

8.  Induction of tolerance by IL-10-treated dendritic cells.

Authors:  K Steinbrink; M Wölfl; H Jonuleit; J Knop; A H Enk
Journal:  J Immunol       Date:  1997-11-15       Impact factor: 5.422

9.  A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis.

Authors:  G Süss; K Shortman
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

10.  Human self-reactive T cell clones expressing identical T cell receptor beta chains differ in their ability to recognize a cryptic self-epitope.

Authors:  S Quaratino; M Feldmann; C M Dayan; O Acuto; M Londei
Journal:  J Exp Med       Date:  1996-02-01       Impact factor: 14.307

View more
  10 in total

1.  A novel cancer therapeutic using thrombospondin 1 in dendritic cells.

Authors:  Tzu-Yang Weng; Shih-Shien Huang; Meng-Chi Yen; Chi-Chen Lin; Yi-Ling Chen; Chiu-Mei Lin; Wei-Ching Chen; Chih-Yang Wang; Jang-Yang Chang; Ming-Derg Lai
Journal:  Mol Ther       Date:  2013-10-15       Impact factor: 11.454

2.  Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases define the migratory characteristics of human monocyte-derived dendritic cells.

Authors:  Mohamed Osman; Micky Tortorella; Marco Londei; Sonia Quaratino
Journal:  Immunology       Date:  2002-01       Impact factor: 7.397

3.  Distinct response of liver myeloid dendritic cells to endotoxin is mediated by IL-27.

Authors:  Yun Chen; Guoping Jiang; Horng-Ren Yang; Xiaodong Gu; Lianfu Wang; Ching-Chuan Hsieh; Hong-Shiue Chou; John J Fung; Shiguang Qian; Lina Lu
Journal:  J Hepatol       Date:  2009-06-13       Impact factor: 25.083

4.  The AIDS-like disease of CD4C/human immunodeficiency virus transgenic mice is associated with accumulation of immature CD11bHi dendritic cells.

Authors:  Johanne Poudrier; Xiaoduan Weng; Denis G Kay; Zaher Hanna; Paul Jolicoeur
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

5.  The cross-regulatory relationship between human dendritic and regulatory T cells and its role in type 1 diabetes mellitus.

Authors:  Hsuen-Wen Chang; Yen-Hung Chow; Pele Chong; Charles Sia
Journal:  Rev Diabet Stud       Date:  2007-08-10

Review 6.  Gene-modified dendritic cells for immunotherapy against cancer.

Authors:  Andreas Lundqvist; Pavel Pisa
Journal:  Med Oncol       Date:  2002       Impact factor: 3.064

Review 7.  Cell Migration Research Based on Organ-on-Chip-Related Approaches.

Authors:  Xiaoou Ren; David Levin; Francis Lin
Journal:  Micromachines (Basel)       Date:  2017-10-31       Impact factor: 2.891

Review 8.  Dendritic Cell-based Immunotherapy for Rheumatoid Arthritis: from Bench to Bedside.

Authors:  Md Selim Ahmed; Yong-Soo Bae
Journal:  Immune Netw       Date:  2016-02-25       Impact factor: 6.303

9.  Recombinant rabies virus with the glycoprotein fused with a DC-binding peptide is an efficacious rabies vaccine.

Authors:  Yachun Zhang; Ming Zhou; Yingying Li; Zhaochen Luo; Huanchun Chen; Min Cui; Zhen F Fu; Ling Zhao
Journal:  Oncotarget       Date:  2017-12-11

10.  A New Concept of Enhancing Immuno-Chemotherapeutic Effects Against B16F10 Tumor via Systemic Administration by Taking Advantages of the Limitation of EPR Effect.

Authors:  Yuting Yang; Xiaowei Tai; Kairong Shi; Shaobo Ruan; Yue Qiu; Zhirong Zhang; Bing Xiang; Qin He
Journal:  Theranostics       Date:  2016-09-12       Impact factor: 11.556

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.